Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-15

FDA Approved: TAMSULOSIN HYDROCHLORIDE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for tamsulosin hydrochloride (Sandoz Inc.), authorizing the continued marketing of the generic with the requested ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamsulosin hydrochloride (tamsulosin hydrochloride)

Snippet

SUPPL AP for TAMSULOSIN HYDROCHLORIDE (TAMSULOSIN HYDROCHLORIDE)